Home » Headlines » Currently Reading:

Morning Headlines 8/2/16

August 1, 2016 Headlines No Comments

Theranos Founder Elizabeth Holmes Introduces New Blood-Testing Device

During a speech at the annual meeting of the American Association for Clinical Chemistry, Theranos CEO Elizabeth Holmes announces that her lab test startup has invented a new analyzer that uses small amounts of blood and performs more tests than the company’s Edison analyzer.

Struggling To Stabilize: 3Rs Litigation And The Future Of The ACA Exchanges

Health Affairs recaps the numerous lawsuits being brought against the federal government by insurers and co-ops struggling to maintain profitability on the ACA marketplaces.

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Researchers using 23andMe’s genome database to look for genetic variants associated with major depressive disorder find 15 previously unknown mutations that correlated with an increased risk of depression.

CMS selects markets for new primary-care payment initiative

CMS will launch the Comprehensive Primary Care Plus program in 14 regions, including  Arkansas, Colorado, Hawaii, Kansas City (MO) Michigan, Montana, New Jersey, North Hudson Valley (NY), Oklahoma, Oregon, Rhode Island, Tennessee and parts of Ohio and Kentucky.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links